Abstract
The global clinical artificial intelligence (AI) research landscape is constantly evolving, with heterogeneity across specialties, disease areas, geographical representation, and development maturity. Continual assessment of this landscape is important for monitoring progress. Taking advantage of developments in natural language processing (NLP), we produce an end-to-end NLP pipeline to automate classification and characterization of all original clinical AI research on MEDLINE, outputting real-time results to a public, interactive dashboard (https://aiforhealth.app/).
Competing Interest Statement
This publication did not receive any direct funding. Views expressed are authors own. JZ receives funding from the Wellcome Trust (203928/Z/16/Z) and acknowledges support from the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College NHS Trust and Imperial College London. SB receives funding from the Wellcome Trust (566701) and holds equity in Owkin. JTT has received research grant support from Innovate UK, NHSX, Office of Life Sciences, Bristol-Meyers-Squibb and Pfizer; has received honorarium from Bayer, Bristol-Meyers-Squibb and Goldman Sachs; holds equity in Amazon, Alphabet, NVidia, Glaxo Smith Kline; and receives royalties from Wiley-Blackwell Publishing. PL is financially supported by Anandamahidol Foundation, Thailand. LAC receives funding from the National Institute of Health (NIBIB R01 EB017205).
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Completing Interests: statement appears at the end
Data Availability
All data and code involved in this study are available in the GitHub repositories described within the paper.